Skip to main content

Longevity Health Holdings, Inc.

corporate_fare Company Profile

Longevity Health Holdings, Inc.

XAGE·OTC·Life Sciences·CIK 0001842939

Longevity Health Holdings, Inc. is a bio-aesthetics company that develops, manufactures, and markets cosmetic skincare and haircare products. The company uses Carmell Secretome and Elevai Exosomes to support skin and hair health. Carmell Secretome is made up of growth factors, proteins, and peptides derived from allogeneic human platelets. Elevai Exosomes contain growth factors, cytokines, peptides, and other small molecules that play a role in the body's natural healing process. Longevity Health Holdings also develops a microemulsion formulation designed to deliver both lipophilic and hydrophilic ingredients without using the "Foul Fourteen," which are 14 potentially harmful excipients often used by other companies to give cosmetic products texture, stability, and other physical and chemical properties. The company has a licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. Founded in 2008, Longevity Health Holdings, Inc. was formerly known as Carmell Corporation and changed its name in March 2025. The company is headquartered in Pittsburgh, Pennsylvania.

Longevity Health Holdings, Inc. (OTC:XAGE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for XAGE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-11, rated 7/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for XAGE spans SCHEDULE 13D, 4, 424B3, 8-K.

Recent high-impact activity:

  • Micro-Cap Longevity Health Puts Itself Up for Strategic Review, Halts Bone-Repair R&D
  • Longevity Health Discloses Going Concern Risk, Q1 Revenue Plunges 23%
  • New CEO Takes 27.9% Stake, Invests $200K to Lead Turnaround Amidst Going Concern Warning
  • CEO Invests $200K, Acquiring Over 30% of Longevity Health Holdings Amidst Going Concern Warning
  • Longevity Health Holdings Discloses Going Concern Doubt, Nasdaq Delisting, and New CEO with $200K Private Placement

Short Interest & Short Volume

1.28 days to cover

FINRA reported short interest of 2,958 shares in XAGE as of the October 30, 2026 settlement, unchanged from the prior period — about 1.3 days to cover at its recent average daily volume. On November 18, 2026, 49.5% of XAGE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,958 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover1.28 at avg daily volume of 2,319
Daily short volume (FINRA facilities)49.5% of 218 shares on November 18, 2026
3-day average short volume46.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with X →
$0.1118
52-week range · as of 2026-04-09 $0.1118 – $397.62
Market cap
$276.73K
Volume
523 (0.1× avg)
3-mo avg 3.6K
Live data · 2026-11-22 10:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XAGE - Latest Insights

XAGE
Nov 11, 2026, 9:13 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.125
Real-time Price: $0.111796 info
Change: -$0.013204 (-11%) info
Market Cap: $276.731K info
XAGE
May 15, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.3201
Real-time Price: $0.111796 info
Change: -$0.208304 (-65%) info
Market Cap: $276.731K info
XAGE
Apr 08, 2026, 9:52 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $0.268
Real-time Price: $0.111796 info
Change: -$0.156204 (-58%) info
Market Cap: $276.731K info
XAGE
Apr 08, 2026, 5:47 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.268
Real-time Price: $0.111796 info
Change: -$0.156204 (-58%) info
Market Cap: $276.731K info
XAGE
Mar 31, 2026, 4:35 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.292875
Real-time Price: $0.111796 info
Change: -$0.181079 (-62%) info
Market Cap: $276.731K info
XAGE
Mar 17, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.400
Real-time Price: $0.111796 info
Change: -$0.288204 (-72%) info
Market Cap: $276.731K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets